English | Français
POSTER SESSION
<– Return to the main agenda of the 2023 symposium.
Africa HPV Roadshow: Accelerating HPV vaccination demand post-Covid-19.
Dr. Tene-Alima ESSOH
HPV vaccine delivery strategy in Cameroon: Progress with the gender-neutral single-dose protocol three years after its introduction
Dr. Andreas Ateke Njoh
Prevalence of Human Papillomavirus (HPV) infection among women in Togo in 2019.
Dr. Yawo Tufa Nyasenu
The single-dose HPV vaccine: an opportunity to accelerate the elimination of cervical cancer in Sub-Saharan Africa
Dr. Freddy Gnangnon
Reaching out of school girls with HPV vaccine using community outreach in Jigawa, Nigeria.
Saleh A. Kwaru Jabeer
Human papillomavirus (HPV) vaccine implementation in Abia State, Nigeria: Lessons learnt from vaccinations in schools.
Chidinma Amuzie
Distribution of high-risk human papillomavirus (HR-HPV) by human immunodeficiency virus (HIV) status in women with cervical cancer in Abidjan, Côte d’Ivoire, 2018-2020.
Dr Simon Boni.
Achieving success in new vaccines introduction through effective planning and establishment of readiness: A case study of Nigeria’s HPV vaccine introduction.
Aisha Umar
Integrating HPV vaccination of young girls with screening for pre-cancerous cervical lesions (PCL-CU): Effectiveness of awareness raising, social mobilization and advocacy in Burkina Faso.
Dr Claude Linda Traoré
Advocacy and community mobilization program for vaccination against human papillomavirus (HPV) in Niger.
Dr Moubarak Ibrahima Madougou
Research to assess the impact and acceptability of a Controlled Temperature Chain (CTC) on HPV vaccination.
Dr Yao Kossia
Operationalizing the integration of HPV vaccination in school and university health services: Adolescent and youth health: The case of Côte d’Ivoire.
Kouassi Séraphin
The role of civil society organizations in HPV prevention: KENYERA – Burundi.
Dr. Jean Claude MUDENDE
Vaccination campaign for the multi-age cohort (MAC) of girls aged 9 to 18 in Côte d’Ivoire in 2024.
Dr. Viou Innocent MASSENON
Experience of the Democratic Republic of Congo in the decision-making process for the introduction of the HPV vaccine.
Dr Djeneba Coulibaly-Traoré